Intellipharmaceutics Logo

Email this page: News Release

Intellipharmaceutics Announces Patent Litigation by Purdue against its Rexista™ Abuse-Deterrent Extended-Release Oxycodone

 

Separate multiple addresses with commas. Maximum 200 characters.
 
 


These email addresses will be used to email the page on your behalf and will not be used by Intellipharmaceutics for any marketing purposes.

Send:       


 
This helps Intellipharmaceutics prevent automated submissions.